RxDoctor Payments Data

Robert Norman, DO

Family Medicine · Orrville, OHNPI 1407168610

Payments from drug & device makers

$671in general payments, 2019–2025

Across 90 payments — averaging $7.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$408
  • E.r. Squibb & Sons, L.L.C.$48
  • Boehringer Ingelheim$41
  • Galderma Laboratories, L.p.$35
  • AstraZeneca$27
  • GSK$26
  • plus $86 from 6 others

What the payments were for

  • Food & beverage$671100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$671 in reported general payments places this provider in the 55th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$47,405
Medicare patients
182
Services billed
796

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban190$182,998
XareltoRivaroxaban72$80,352
TrulicityDulaglutide56$71,919
Trelegy ElliptaFluticasone/Umeclidin/Vilanter76$61,352
OzempicSemaglutide54$59,338
MounjaroTirzepatide25$32,892
JardianceEmpagliflozin23$26,268
JanuviaSitagliptin Phosphate17$16,851
Spiriva RespimatTiotropium Bromide16$10,383
Breo ElliptaFluticasone/Vilanterol16$7,591
SymbicortBudesonide/Formoterol Fumarate25$6,653
MyrbetriqMirabegron13$6,591
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$6,508
Lantus SolostarInsulin Glargine,hum.Rec.Anlog42$6,366
Albuterol Sulfate HfaAlbuterol Sulfate234$5,902

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$16$182,998190 claims
Lilly USA, LLCTrulicity, Mounjaro$11$104,81081 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta$26$80,058115 claims
Novo NordiskOzempic$408$59,33854 claims
Boehringer IngelheimJardiance, Spiriva Respimat$41$36,65239 claims
MerckJanuvia$13$16,85117 claims
AstraZenecaSymbicort$27$6,65325 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Orrville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →